- Home
- OP vs ONCO Comparison
OP vs ONCO Comparison
Compare OP & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OP
- ONCO
- Stock Information
- Founded
- OP 2021
- ONCO 2018
- Country
- OP Greece
- ONCO United States
- Employees
- OP N/A
- ONCO N/A
- Industry
- OP
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- OP
- ONCO Health Care
- Exchange
- OP Nasdaq
- ONCO Nasdaq
- Market Cap
- OP 5.3M
- ONCO 1.8M
- IPO Year
- OP N/A
- ONCO 2022
- Fundamental
- Price
- OP $1.36
- ONCO $4.23
- Analyst Decision
- OP
- ONCO
- Analyst Count
- OP 0
- ONCO 0
- Target Price
- OP N/A
- ONCO N/A
- AVG Volume (30 Days)
- OP 9.4M
- ONCO 229.9K
- Earning Date
- OP 08-06-2025
- ONCO 08-28-2025
- Dividend Yield
- OP N/A
- ONCO N/A
- EPS Growth
- OP N/A
- ONCO N/A
- EPS
- OP N/A
- ONCO N/A
- Revenue
- OP $25,702,000.00
- ONCO $1,925,313.00
- Revenue This Year
- OP N/A
- ONCO N/A
- Revenue Next Year
- OP N/A
- ONCO N/A
- P/E Ratio
- OP N/A
- ONCO N/A
- Revenue Growth
- OP 35.58
- ONCO 153.70
- 52 Week Low
- OP $0.63
- ONCO $3.82
- 52 Week High
- OP $3.17
- ONCO $1,190.00
- Technical
- Relative Strength Index (RSI)
- OP 48.71
- ONCO 40.01
- Support Level
- OP $1.16
- ONCO $4.19
- Resistance Level
- OP $1.67
- ONCO $5.17
- Average True Range (ATR)
- OP 0.25
- ONCO 0.45
- MACD
- OP -0.10
- ONCO 0.07
- Stochastic Oscillator
- OP 12.90
- ONCO 21.76
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.